معرفی
Dr. Justin Belcher is an Associate Professor of Medicine (Nephrology) at Yale University School of Medicine. He specializes in acute kidney injury (AKI), chronic kidney disease, and critical care nephrology, with a focus on cirrhosis-related kidney dysfunction. His research emphasizes biomarker development for AKI diagnosis/prognosis and hepatorenal syndrome management.
Education & Training:
- B.A. in History, Williams College (1999)
- M.D., Drexel University College of Medicine (2004)
- Ph.D. in Clinical Investigation, Yale University (2015)
- Residency & Chief Residency in Internal Medicine, George Washington University (2005-2008)
- Nephrology Fellowship, Yale University (2011)
Research Interests: Dr. Belcher’s work integrates clinical nephrology with translational research, particularly in AKI pathophysiology among cirrhotic patients. His lab explores novel biomarkers (e.g., urinary CCL14, NGAL) to improve diagnostic accuracy and therapeutic decision-making.
Publications: Over 20 peer-reviewed articles (2024 highlights include HRS-HARMONY Consortium studies on AKI outcomes in cirrhosis). Key themes: hepatorenal syndrome treatment, biomarker validation, and clinical trial design for vasoconstrictor therapies.
Awards: 2023 Fellow of the American Society of Nephrology; NIH Loan Repayment Award (2010); multiple residency/fellowship honors.
Teaching & Mentorship: Actively involved in medical student/resident education through lectures, workshops, and mentorship programs. Serves as a role model for clinician-scientists in nephrology.
Professional Roles: Associate Editor for BMC Nephrology; peer reviewer for American Journal of Kidney Diseases and others; member of American Society of Nephrology and American Association for the Study of Liver Diseases.
